| Schedule of segment and corporate information |
| | | | | | | | | | | | | | | Segment and corporate information | in € K | | | | | | | | | | | | | | | | | Care | | | | Care | | Total | | Inter-segment | | | | | | | Delivery | | Value-Based Care | | Enablement | | Segment | | eliminations | | Corporate | | Total | 2025 | | | | | | | | | | | | | | | Revenue from healthcare services(1) | | 12,966,604 | | 130,663 | | — | | 13,097,267 | | — | | — | | 13,097,267 | Revenue from healthcare products(1) | | 271,717 | | — | | 4,054,006 | | 4,325,723 | | — | | — | | 4,325,723 | Revenue from contracts with customers(1) | | 13,238,321 | | 130,663 | | 4,054,006 | | 17,422,990 | | — | | — | | 17,422,990 | Revenue from insurance contracts(1) | | — | | 2,116,710 | | — | | 2,116,710 | | — | | — | | 2,116,710 | Revenue from lease contracts(1) | | — | | — | | 87,902 | | 87,902 | | — | | — | | 87,902 | Revenue from external customers | | 13,238,321 | | 2,247,373 | | 4,141,908 | | 19,627,602 | | — | | — | | 19,627,602 | Inter-segment revenue | | 497,951 | | — | | 1,334,279 | | 1,832,230 | | (1,832,230) | | — | | — | Revenue | | 13,736,272 | | 2,247,373 | | 5,476,187 | | 21,459,832 | | (1,832,230) | | — | | 19,627,602 | Costs of revenue | | (10,517,158) | | (2,132,390) | | (3,780,225) | | (16,429,773) | | 1,835,995 | | (4,895) | | (14,598,673) | Research and development | | — | | — | | (158,181) | | (158,181) | | — | | 206 | | (157,975) | Operating income (loss) | | 1,614,099 | | 1,225 | | 325,893 | | 1,941,217 | | 4,924 | | (119,105) | | 1,827,036 | Interest | | | | | | | | | | | | | | (314,798) | Income before income taxes | | | | | | | | | | | | | | 1,512,238 | Depreciation and amortization | | (976,400) | | (4,939) | | (457,103) | | (1,438,442) | | 41,991 | | (66,962) | | (1,463,413) | Impairment loss | | (31,583) | | (2,118) | | (3,288) | | (36,989) | | — | | (7) | | (36,996) | Income (loss) from equity method investees | | 181,368 | | — | | — | | 181,368 | | — | | — | | 181,368 | Total assets(1) | | 39,239,152 | | 640,213 | | 13,555,088 | | 53,434,453 | | (33,430,072) | | 10,997,952 | | 31,002,333 | thereof investment in equity method investees(1) | | 663,652 | | — | | — | | 663,652 | | — | | — | | 663,652 | Additions of property, plant and equipment, intangible assets and right-of-use assets(1) | | 726,505 | | 364 | | 736,725 | | 1,463,594 | | (29,475) | | 44,432 | | 1,478,551 | | | | | | | | | | | | | | | | 2024 | | | | | | | | | | | | | | | Revenue from healthcare services(1) | | 13,332,931 | | 138,432 | | — | | 13,471,363 | | — | | — | | 13,471,363 | Revenue from healthcare products(1) | | 189,733 | | — | | 3,996,462 | | 4,186,195 | | — | | — | | 4,186,195 | Revenue from contracts with customers(1) | | 13,522,664 | | 138,432 | | 3,996,462 | | 17,657,558 | | — | | — | | 17,657,558 | Revenue from insurance contracts(1) | | — | | 1,614,024 | | — | | 1,614,024 | | | | | | 1,614,024 | Revenue from lease contracts(1) | | — | | — | | 64,327 | | 64,327 | | — | | — | | 64,327 | Revenue from external customers | | 13,522,664 | | 1,752,456 | | 4,060,789 | | 19,335,909 | | — | | — | | 19,335,909 | Inter-segment revenue | | 480,797 | | — | | 1,495,745 | | 1,976,542 | | (1,976,542) | | — | | — | Revenue | | 14,003,461 | | 1,752,456 | | 5,556,534 | | 21,312,451 | | (1,976,542) | | — | | 19,335,909 | Costs of revenue | | (10,922,292) | | (1,678,638) | | (3,915,405) | | (16,516,335) | | 1,952,344 | | (15,266) | | (14,579,257) | Research and development | | (41) | | — | | (183,449) | | (183,490) | | — | | (3) | | (183,493) | Operating income (loss) | | 1,217,971 | | (28,152) | | 267,098 | | 1,456,917 | | (16,571) | | (47,951) | | 1,392,395 | Interest | | | | | | | | | | | | | | (335,469) | Income before income taxes | | | | | | | | | | | | | | 1,056,926 | Depreciation and amortization | | (1,040,805) | | (4,375) | | (462,507) | | (1,507,687) | | 44,073 | | (71,922) | | (1,535,536) | Impairment loss | | (185,156) | | — | | (21,555) | | (206,711) | | — | | (10) | | (206,721) | Income (loss) from equity method investees | | 134,875 | | — | | — | | 134,875 | | — | | — | | 134,875 | Total assets(1) | | 42,719,297 | | 679,712 | | 14,685,989 | | 58,084,998 | | (35,330,991) | | 10,812,572 | | 33,566,579 | thereof investment in equity method investees(1) | | 620,831 | | — | | — | | 620,831 | | — | | — | | 620,831 | Additions of property, plant and equipment, intangible assets and right-of-use assets(1) | | 882,599 | | 480 | | 506,501 | | 1,389,580 | | (56,301) | | 41,450 | | 1,374,729 | | | | | | | | | | | | | | | | 2023 | | | | | | | | | | | | | | | Revenue from healthcare services(1) | | 14,116,820 | | 49,976 | | — | | 14,166,796 | | — | | — | | 14,166,796 | Revenue from healthcare products(1) | | 184,021 | | — | | 3,795,101 | | 3,979,122 | | — | | — | | 3,979,122 | Revenue from contracts with customers(1) | | 14,300,841 | | 49,976 | | 3,795,101 | | 18,145,918 | | — | | — | | 18,145,918 | Revenue from insurance contracts(1) | | — | | 1,227,140 | | — | | 1,227,140 | | | | | | 1,227,140 | Revenue from lease contracts(1) | | — | | — | | 80,559 | | 80,559 | | — | | — | | 80,559 | Revenue from external customers | | 14,300,841 | | 1,277,116 | | 3,875,660 | | 19,453,617 | | — | | — | | 19,453,617 | Inter-segment revenue | | 447,770 | | — | | 1,469,768 | | 1,917,538 | | (1,917,538) | | — | | — | Revenue | | 14,748,611 | | 1,277,116 | | 5,345,428 | | 21,371,155 | | (1,917,538) | | — | | 19,453,617 | Costs of revenue | | (11,348,785) | | (1,250,330) | | (3,834,084) | | (16,433,199) | | 1,904,833 | | (246) | | (14,528,612) | Research and development | | (42) | | — | | (231,656) | | (231,698) | | — | | (272) | | (231,970) | Operating income (loss) | | 1,611,544 | | (95,732) | | (66,521) | | 1,449,291 | | (12,705) | | (67,148) | | 1,369,438 | Interest | | | | | | | | | | | | | | (336,423) | Income before income taxes | | | | | | | | | | | | | | 1,033,015 | Depreciation and amortization | | (1,120,107) | | (5,518) | | (457,497) | | (1,583,122) | | 41,079 | | (70,694) | | (1,612,737) | Impairment loss | | (89,963) | | — | | (49,154) | | (139,117) | | — | | (117) | | (139,234) | Income (loss) from equity method investees | | 115,354 | | — | | 6,431 | | 121,785 | | — | | — | | 121,785 | Total assets(1) | | 41,058,324 | | 655,345 | | 13,392,422 | | 55,106,091 | | (31,135,993) | | 9,959,710 | | 33,929,808 | thereof investment in equity method investees(1) | | 642,928 | | — | | — | | 642,928 | | — | | — | | 642,928 | Additions of property, plant and equipment, intangible assets and right-of-use assets(1) | | 775,274 | | 860 | | 528,769 | | 1,304,903 | | (31,118) | | 42,953 | | 1,316,738 |
| (1) | These line items are included to comply with requirements under IFRS 8 and IFRS 15 or are provided on a voluntary basis, but not included in the information regularly reviewed by the chief operating decision maker. |
|